Acknowledgement
Supported by : National Research Foundation of Korea (NRF)
References
- Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 2008; 68: 499-509. https://doi.org/10.1111/j.1365-2265.2007.03073.x
- Norling A, Hirschberg AL, Rodriguez-Wallberg KA, Iwarsson E, Wedell A, Barbaro M. Identification of a duplication within the GDF9 gene and novel candidate genes for primary ovarian insufficiency (POI) by a customized highresolution array comparative genomic hybridization platform. Hum Reprod 2014; 29: 1818-27. https://doi.org/10.1093/humrep/deu149
- Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health 2014; 6: 235-43.
- Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360: 606-14. https://doi.org/10.1056/NEJMcp0808697
- Qin Y, Sun M, You L, Wei D, Sun J, Liang X, et al. ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure. Orphanet J Rare Dis 2012; 7: 5. https://doi.org/10.1186/1750-1172-7-5
- Ameratunga D, Weston G, Osianlis T, Catt J, Vollenhoven B. In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? J Assist Reprod Genet 2009; 26: 511-4. https://doi.org/10.1007/s10815-009-9351-5
- Sills ES, Brady AC, Omar AB, Walsh DJ, Salma U, Walsh AP. IVF for premature ovarian failure: first reported births using oocytes donated from a twin sister. Reprod Biol Endocrinol 2010; 8: 31. https://doi.org/10.1186/1477-7827-8-31
- Hernandez-Angeles C, Castelo-Branco C. Early menopause: A hazard to a woman's health. Indian J Med Res 2016; 143: 420-7. https://doi.org/10.4103/0971-5916.184283
- Cartwright B, Robinson J, Seed PT, Fogelman I, Rymer J. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: A randomized controlled trial of the effects on bone mineral density. J Clin Endocrinol Metab 2016; 101: 3497-505. https://doi.org/10.1210/jc.2015-4063
- Slopien R, Warenik-Szymankiewicz A. Premature ovarian failure: diagnosis and treatment. Clin Exp Obstet Gynecol 2014; 41: 659-61.
- Sun M, Wang S, Li Y, Yu L, Gu F, Wang C, et al. Adiposederived stem cells improved mouse ovary function after chemotherapy-induced ovary failure. Stem Cell Res Ther 2013; 4: 80. https://doi.org/10.1186/scrt231
- Terraciano P, Garcez T, Ayres L, Durli I, Baggio M, Kuhl CP, et al. Cell therapy for chemically induced ovarian failure in mice. Stem Cells Int 2014; 2014: 720753.
- Lai D, Wang F, Yao X, Zhang Q, Wu X, Xiang C. Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure. J Transl Med 2015; 13: 155. https://doi.org/10.1186/s12967-015-0516-y
- Wang Z, Wang Y, Yang T, Li J, Yang X. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther 2017; 8: 11. https://doi.org/10.1186/s13287-016-0458-1
- Rebar RW. Premature ovarian “failure” in the adolescent. Ann N Y Acad Sci 2008; 1135: 138-45. https://doi.org/10.1196/annals.1429.000
- Qin Y, Jiao X, Simpson JL, Chen ZJ. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update 2015; 21: 787-808. https://doi.org/10.1093/humupd/dmv036
- Liu TE, Wang S, Zhang L, Guo L, Yu Z, Chen C, et al. Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway. Exp Ther Med 2016; 12: 215-21. https://doi.org/10.3892/etm.2016.3326
- He L, Ling L, Wei T, Wang Y, Xiong Z. Ginsenoside Rg1 improves fertility and reduces ovarian pathological damages in premature ovarian failure model of mice. Exp Biol Med (Maywood) 2017; 242: 683-91. https://doi.org/10.1177/1535370217693323
- Jiang Y, Zhao J, Qi HJ, Li XL, Zhang SR, Song DW, et al. Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide. J Zhejiang Univ Sci B 2013; 14: 318-24. https://doi.org/10.1631/jzus.B1200181
- Zhang T, Yan D, Yang Y, Ma A, Li L, Wang Z, et al. The comparison of animal models for premature ovarian failure established by several different source of inducers. Regul Toxicol Pharmacol 2016; 81: 223-32.
- Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, et al. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2). Semin Oncol 1993; 20: 33-8.
- de Magalhaes-Silverman M, Lister J, Rybka W, Wilson J, Ball E. Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma. Bone Marrow Transplant 1997; 19: 777-81. https://doi.org/10.1038/sj.bmt.1700733
- Han YS, Lee AR, Song HK, Choi JI, Kim JH, Kim MR, et al. Ovarian volume in Korean women with polycystic ovary syndrome and its related factors. J Menopausal Med 2017; 23: 25-31. https://doi.org/10.6118/jmm.2017.23.1.25
- Kim HG, Song YJ, Na YJ, Yang J, Choi OH. A rare case of an autoamputated ovary with mature cystic teratoma. J Menopausal Med 2017; 23: 74-6. https://doi.org/10.6118/jmm.2017.23.1.74
Cited by
- Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice vol.11, pp.1, 2018, https://doi.org/10.1186/s13287-020-01972-5
- Menstrual blood CD146+ mesenchymal stem cells reduced fibrosis rate in the rat model of premature ovarian failure vol.39, pp.8, 2018, https://doi.org/10.1002/cbf.3669
- Autologous transplantation of thecal stem cells restores ovarian function in nonhuman primates vol.7, pp.1, 2018, https://doi.org/10.1038/s41421-021-00291-0